Literature DB >> 11102331

Deliberate self-harm and antidepressant drugs. Investigation of a possible link.

S Donovan1, A Clayton, M Beeharry, S Jones, C Kirk, K Waters, D Gardner, J Faulding, R Madeley.   

Abstract

BACKGROUND: It is not clear if the frequency of deliberate self-harm (DSH) is the same in patients taking different pharmacological classes of antidepressant drugs. AIMS: To compare the frequency of DSH in patients who had been prescribed a tricyclic antidepressant (TCA) or a selective serotonin reuptake inhibitor (SSRI) prior to the DSH event.
METHOD: This was a prospective study in 2776 consecutive DSH cases attending an accident and emergency department. The incidence of DSH in TCA-treated cases and SSRI-treated cases is expressed as number of DSH events per 10 000 prescriptions of each antidepressant.
RESULTS: Significantly more DSH events occurred following the prescription of an SSRI than that of a TCA (P<0.001). The occurrence of DSH was highest with fluoxetine and lowest with amitriptyline.
CONCLUSIONS: Merely prescribing safer-in-overdose antidepressants is unlikely to reduce the overall morbidity from DSH.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11102331     DOI: 10.1192/bjp.177.6.551

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  13 in total

Review 1.  Antidepressants and suicide: risk-benefit conundrums.

Authors:  David Healy; Chris Whitaker
Journal:  J Psychiatry Neurosci       Date:  2003-09       Impact factor: 6.186

2.  Lessons from the Women's Health Initiative: primary prevention and gender health.

Authors:  Anna Day
Journal:  CMAJ       Date:  2002-08-20       Impact factor: 8.262

3.  Suicide and self-harm following prescription of SSRIs and other antidepressants: confounding by indication.

Authors:  Rebecca C Didham; Doug W McConnell; Hayden J Blair; David M Reith
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

4.  The Food and Drug Administration's deliberations on antidepressant use in pediatric patients.

Authors:  Laurel K Leslie; Thomas B Newman; P Joan Chesney; James M Perrin
Journal:  Pediatrics       Date:  2005-07       Impact factor: 7.124

Review 5.  Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12-01       Impact factor: 5.270

6.  Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?

Authors:  D N Bateman; J Chick; A M Good; C A Kelly; G Masterton
Journal:  Eur J Clin Pharmacol       Date:  2004-04-09       Impact factor: 2.953

Review 7.  Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies.

Authors:  Corrado Barbui; Eleonora Esposito; Andrea Cipriani
Journal:  CMAJ       Date:  2009-02-03       Impact factor: 8.262

Review 8.  Treating depressed children with antidepressants: more harm than benefit?

Authors:  David Antonuccio
Journal:  J Clin Psychol Med Settings       Date:  2008-06

9.  Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders.

Authors:  Saurabh Gupta; Kenneth Ronald Gersing; Alaattin Erkanli; Tal Burt
Journal:  Psychiatr Q       Date:  2016-06

10.  Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial.

Authors:  Nader Perroud; Rudolf Uher; Andrej Marusic; Marcella Rietschel; Ole Mors; Neven Henigsberg; Joanna Hauser; Wolfgang Maier; Daniel Souery; Anna Placentino; Aleksandra Szczepankiewicz; Lisbeth Jorgensen; Jana Strohmaier; Astrid Zobel; Caterina Giovannini; Amanda Elkin; Cerisse Gunasinghe; Joanna Gray; Desmond Campbell; Bhanu Gupta; Anne E Farmer; Peter McGuffin; Katherine J Aitchison
Journal:  BMC Med       Date:  2009-10-15       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.